Summary of Purpose
This study is a non-randomized, Phase 2 clinical trial designed to assess optical cerebral blood flow (CBF) response to bolus normal saline. Subjects will have had an ischemic stroke within 96 hours of enrollment. The study intervention will be a one hour monitoring session. There will be a 15 minute baseline measurement period, followed by intravenous administration of 500cc of 0.9% NaCl over 30 minutes, and...Read More →
The following dates are available for this trial. Trial information last updated on 30 August 2016.
|1 Oct 2013||23 Oct 2013||1 Apr 2017||Unavailable||1 Aug 2016||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Allocation: Non-Randomized
- Masking: Open Label
- Intervention: Single Group Assignment